semaglutide and kidney health FDA Approves to Reduce Disease, Cardiovascular Death Risk in Adults With Type 2 Diabetes, Chronic Kidney Disease Semaglutide lowers UACR in overweight

Current FDA-approved prescribing information for semaglutide does not require routine thyroid monitoring, including serum calcitonin measurements or thyroid ultrasound surveillance, in patients without risk factors

Antarctic-G : helps protect healthy skin from external stressors by moisturizing and toning the skin

According to the SmPC, headaches are classified as a 'common' adverse reaction (affecting between 1 in 10 and 1 in 100 patients)

Modulate Taste Perception: Some users report changes in taste, particularly for high-fat or sugary foods, which can naturally lead to reduced consumption of calorie-dense items

It is important to note that Phase 2 data, whilst promising, do not yet constitute the full evidence base required for regulatory approval